Tibet Pharma Investors Escape Dismissal For Now In IPO Row
Law360 Law360 (July 27, 2018, 8:00 PM EDT) -- A New Jersey federal judge on Friday rejected a bid to remove three lead plaintiffs from a class action alleging Tibet Pharmaceuticals Inc. lied about its financial health before its 2011 initial public offering ... |
https://ift.tt/2mQZWVf
No comments:
Post a Comment